Search Results
Results found for "Brian Matthews"
- 📰 GPCR Weekly News, May 29 to June 4, 2023
Methods & Updates in GPCR Research Illuminating the brain-genetically encoded single wavelength fluorescent
- 📰 GPCR Weekly News
Superconserved receptors expressed in the brain: Expression, function, motifs and evolution of an orphan
- 📰 GPCR Weekly News, October 30 to November 4, 2023
Therapy Research Structure Therapeutics Receives R&D Achievement of the Year Award for GPCR Research Bryan
- 📰 GPCR Weekly News, January 29 to February 4, 2024
perspectives of GPCR-based genetically encoded fluorescent indicators for neuromodulators Illuminating the brain-genetically
- Regulators of G-protein signaling: essential players in GPCR signaling
members of the RGS family are selective for certain GPCRs, as a proof RGS4 which is expressed in the brain
- New role of β-arrestins in MOR signaling
Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain.
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
finesse dilemma: When orthosterics hijack the signal vs. when allosterics fine-tune (and why that matters breakthrough: pHSense , a reagent designed to make receptor trafficking visible in the systems that matter Why It Matters Instead of imaging-heavy workflows, pHSense offers a no-wash, plate-reader–ready, high-throughput Subtype specificity: selectively track receptor subtypes in complex brain tissue. Why It Matters In the CNS, where receptor localization and real-time signaling shape therapeutic outcomes
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
protein intake setpoint in Drosophila Kappa Opioid Receptor Activation Induces Epigenetic Silencing of Brain-Derived
- 📰 GPCR Weekly News, January 30 to February 5, 2023
Reviews, GPCRs, and more Understanding Neuropeptide Transmission in the Brain by Optical Uncaging and
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Practical approaches to evaluating and optimizing brain exposure in early drug discovery. serotonin 5-HT2A receptor inverse agonism for Gαi1- and neutral antagonism for Gαq/11-proteins in human brain
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
Pyrazole Antagonists of the CB1 Receptor with Reduced Brain Penetration.





